Capricor Therapeutics (CAPR)

Capricor Therapeutics (CAPR) Financial Statements


Capricor Therapeutics Financial Overview

Capricor Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.181; its P/E ratio is -3.62; Capricor Therapeutics is scheduled to report earnings on May 11, 2023, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 959.90K$ 1.59M$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -8.07M$ -6.48M$ -7.32M$ -7.83M$ -6.38M
EBITDA$ -7.87M$ -6.34M$ -7.21M$ -7.74M$ -6.30M
Net Income Common Stockholders$ -7.72M$ -6.37M$ -7.11M$ -7.82M$ -6.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.42M$ 46.61M$ 51.42M$ 58.33M$ 34.89M
Total Assets$ 50.09M$ 53.93M$ 58.07M$ 64.92M$ 41.33M
Total Debt$ 2.56M$ 2.78M$ 2.74M$ 2.80M$ 2.87M
Net Debt$ -38.86M$ -43.83M$ -48.68M$ -55.53M$ -32.01M
Total Liabilities$ 38.31M$ 38.50M$ 39.34M$ 40.28M$ 9.96M
Stockholders Equity$ 11.79M$ 15.43M$ 18.73M$ 24.64M$ 31.37M
Cash Flow-
Free Cash Flow$ -8.12M$ -6.78M$ -6.95M$ 23.42M$ -6.00M
Operating Cash Flow$ -6.90M$ -5.69M$ -6.54M$ 24.05M$ -5.63M
Investing Cash Flow$ 5.14M$ -4.18M$ -35.41M$ -625.36K$ -368.67K
Financing Cash Flow$ 2.95M$ 1.88M$ 15.01K$ 27.46K$ 42.37K
Currency in USD

Capricor Therapeutics Earnings and Revenue History

Capricor Therapeutics Debt to Assets

Capricor Therapeutics Cash Flow

Capricor Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis